Drugs Made in America Acquisition Corp. (DMAAU) Prices $200M IPO
Drugs Made in America Acquisition Corp. (NASDAQ:DMAAU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “DMAAU”, Tuesday, January 28, 2025.
...READ MORE